Synapse - Natalie Slupe

Natalie Slupe

Research Focus

Research and Technology Management; Clinical Research Supervisor

Recent additions – View all

Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
Journal Article

Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
Blood (2025)

Fulltext@MSK | Save
A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
Meeting Abstract

Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
Blood (2023)

Fulltext@MSK | Save
Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL
Meeting Abstract

Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

Co-authors at MSK

3

Chabowska
3

Grieve
3

Kumar
3

Labarre
3

Mi
3

Owens
3

Seshan
3

Zelenetz
2

Caron
2

Dogan
2

Falchi
2

Joseph
2

Lue
2

Moskowitz
2

Salles
1

Abdel-W...
1

Carter
1

Choma
1

Epstein...
1

Flaherty
1

Geyer
1

Hamilton
1

Mahajan
1

Noy
1

Palomba
1

Ramos A...
1

Roeker
1

Thompson

Types of Work

Publications

Blood (2)
Hematological Oncology (1)